维普中文期刊产品整合服务
229篇 您的检索式:作者名="Berry DA"
    题名 作者 年代 出处 被引量
1Estrogenreceptor status and outcomes of modem chemotherapy for patients with node-positive breast cancer 显示文摘Berry DA Cirrincione C Henderson IC 2006JAMA2006,295,14:1
2HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node- positive breast cancer显示文摘Berry DA Muss HB Thor AD 2000J Clin Oncol2000,18,20:1
3Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer显示文摘Henderson IC Berry DA Demetri GD 2003J Clin Oncol2003,21,6:1
4Impact of neoadjuvant chemotherapy plus HER2-targeting on breast conservation rates:Surgical results from CALGB 40601 (Alliance)显示文摘Ollila DW Berry DA Cirrincione C 0,,15:1
5Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of Intergroup Trial C9741/Caneer and Leukemia Group B Trial 9741 显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oneol2003,21,8:1
6Adjuvant chemotherapy in older women with early-stage breast cancer显示文摘Muss HB Berry DA Cirrincione CT 2009N Engl J Med2009,360,20:1
7Adjuvant chemotherapy in older women with early-stage breast cancer显示文摘Muss HB Berry DA Cirrincione CT 2009N Engl J Med2009,360,20:1
8Estrogen-receptor status and outcomes of moderm chemotherapy for patients with node-positive breast cancer显示文摘Berry DA Cirrincione C Henderson IC 2006JAMA2006,295,14:1
9Improved outcomes from adding sequential paclixaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer显示文摘Henderson IC Berry DA Demetri GD 2003J Clin Oncol2003,21,8:1
10Six cycles of doxorubicin and cyclophosphamide or paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in woman with zero to three positive axillary nodes:Cancer and Leukemia Group B40101显示文摘Shulman LN Cirrincione CT Berry DA 2012J Chin Oncol2012,30,33:1
11Estrogen recep tor status and outcomes of modern chemotherapy for patients with node-positive breast cancer 显示文摘Berry DA Cirrincione C Henderson IC 2006JAMA2006,295,14:1
12Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer显示文摘Henderson IC Berry DA Demetri GD 2003J Clin Oncol2003,21,6:1
13Pathologic Com- plete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL-CALGB 150007/150012 ,ACRIN 6657显示文摘Esserman LJ Berry DA Carey L 2012J Clin Oncol2012,30,26:1
14Comparison of doxorubicin and cyclophosphamide versus sigle-agent paclitaxel as adjuvant therapy for breast cancer in woman with zero to three positive axillary nodes:CALGB 40101(Alliance)显示文摘Shulman LN Cirrincione CT Berry DA 2014J Chin Oncol2014,32,22:1
15Dose and dose intensity as detenninats of outcome in the adjuvant treatment of breast cancer 显示文摘Budman DR Berry DA Cirrincione CT 1998J Nail Cancer Inst1998,90,19:1
16Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C97411Cancer and Leukemia Group B Trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
17Oesophagostomum radiatum: the effect of different adjuvants on vaccination with a partially purified protective antigen显示文摘 Fitzgerald CJ Berrie DA 1993Vet Parasitol1993,49,24:1
18Estrogen-receptor sta- tus and outcomes of modem chemotherapy for patients with nodepositive breast cancer显示文摘Berry DA Cirrincione C Henderson IC 2006JAMA2006,295,14:1
19Adjuvant chemotherapy in older women with early-stage breast cancer 显示文摘Muss liB Berry DA Cirrincione CT 2009N Engl J Med2009,360,20:1
20Effect of screening and adjuvant therapy on mortality from breast cancer显示文摘Berry DA Cronin KA Plevritis SK 2005N Engl J Med2005,353,17:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费